Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 17.2
(6.57%)
CNY 17.2
(6.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 60.4 Million CNY | -16.84% |
| 2022 | 72.64 Million CNY | -26.64% |
| 2021 | 99.01 Million CNY | -87.09% |
| 2020 | 767.23 Million CNY | -18.19% |
| 2019 | 937.78 Million CNY | 36.26% |
| 2018 | 688.2 Million CNY | 26.28% |
| 2017 | 545 Million CNY | 5405.05% |
| 2016 | 9.9 Million CNY | 1403.25% |
| 2015 | 658.57 Thousand CNY | -97.37% |
| 2014 | 25 Million CNY | 6055.1% |
| 2013 | 406.16 Thousand CNY | -91.88% |
| 2012 | 5 Million CNY | 0.0% |
| 2011 | 5 Million CNY | 25.0% |
| 2010 | 4 Million CNY | -70.91% |
| 2009 | 13.75 Million CNY | 14.58% |
| 2008 | 12 Million CNY | 20.0% |
| 2007 | 10 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 395.39 Million CNY | -26.73% |
| 2024 Q1 | 59.55 Million CNY | -1.42% |
| 2024 Q2 | 539.63 Million CNY | 806.15% |
| 2023 Q2 | 71.28 Million CNY | 0.36% |
| 2023 Q4 | 60.4 Million CNY | -14.82% |
| 2023 Q1 | 71.02 Million CNY | -2.23% |
| 2023 FY | 60.4 Million CNY | -16.84% |
| 2023 Q3 | 70.91 Million CNY | -0.51% |
| 2022 Q4 | 72.64 Million CNY | -0.66% |
| 2022 Q3 | 73.12 Million CNY | -17.81% |
| 2022 Q1 | 93.99 Million CNY | -5.07% |
| 2022 Q2 | 88.97 Million CNY | -5.34% |
| 2022 FY | 72.64 Million CNY | -26.64% |
| 2021 Q2 | 753.5 Million CNY | -3.73% |
| 2021 FY | 99.01 Million CNY | -87.09% |
| 2021 Q1 | 782.67 Million CNY | 2.01% |
| 2021 Q3 | 746.79 Million CNY | -0.89% |
| 2021 Q4 | 99.01 Million CNY | -86.74% |
| 2020 FY | 767.23 Million CNY | -18.19% |
| 2020 Q3 | 802 Million CNY | -8.82% |
| 2020 Q2 | 879.61 Million CNY | -7.08% |
| 2020 Q1 | 946.6 Million CNY | 0.94% |
| 2020 Q4 | 767.23 Million CNY | -4.34% |
| 2019 Q2 | 854.81 Million CNY | 21.28% |
| 2019 Q4 | 937.78 Million CNY | 12.58% |
| 2019 FY | 937.78 Million CNY | 36.26% |
| 2019 Q1 | 704.83 Million CNY | 2.42% |
| 2019 Q3 | 832.98 Million CNY | -2.55% |
| 2018 Q4 | 688.2 Million CNY | 14.66% |
| 2018 FY | 688.2 Million CNY | 26.28% |
| 2018 Q3 | 600.19 Million CNY | 3.13% |
| 2018 Q1 | 582 Million CNY | 6.79% |
| 2018 Q2 | 582 Million CNY | 0.0% |
| 2017 Q3 | 175 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 FY | 545 Million CNY | 5405.05% |
| 2017 Q4 | 545 Million CNY | 211.43% |
| 2016 Q3 | 23.9 Million CNY | -91.9% |
| 2016 Q2 | 295 Million CNY | 0.0% |
| 2016 Q4 | 9.9 Million CNY | -58.58% |
| 2016 FY | 9.9 Million CNY | 1403.25% |
| 2016 Q1 | 295 Million CNY | 44693.75% |
| 2015 Q1 | 15 Million CNY | -40.0% |
| 2015 FY | 658.57 Thousand CNY | -97.37% |
| 2015 Q2 | 15 Million CNY | 0.0% |
| 2015 Q3 | 15 Million CNY | 0.0% |
| 2015 Q4 | 658.57 Thousand CNY | -95.61% |
| 2014 Q2 | 404.95 Thousand CNY | -0.3% |
| 2014 FY | 25 Million CNY | 6055.1% |
| 2014 Q4 | 25 Million CNY | 400.0% |
| 2014 Q3 | 5 Million CNY | 1134.71% |
| 2014 Q1 | 406.16 Thousand CNY | 0.0% |
| 2013 Q3 | 339.3 Thousand CNY | -53.48% |
| 2013 Q1 | 748.66 Thousand CNY | -85.03% |
| 2013 FY | 406.16 Thousand CNY | -91.88% |
| 2013 Q4 | 406.16 Thousand CNY | 19.7% |
| 2013 Q2 | 729.37 Thousand CNY | -2.58% |
| 2012 Q2 | 5 Million CNY | 0.0% |
| 2012 FY | 5 Million CNY | 0.0% |
| 2012 Q1 | 5 Million CNY | 0.0% |
| 2012 Q4 | 5 Million CNY | 0.0% |
| 2012 Q3 | 5 Million CNY | 0.0% |
| 2011 Q2 | 4 Million CNY | 0.0% |
| 2011 Q3 | 20 Million CNY | 400.0% |
| 2011 FY | 5 Million CNY | 25.0% |
| 2011 Q4 | 5 Million CNY | -75.0% |
| 2011 Q1 | 4 Million CNY | 0.0% |
| 2010 Q3 | 14 Million CNY | -52.94% |
| 2010 Q2 | 29.75 Million CNY | 20.2% |
| 2010 FY | 4 Million CNY | -70.91% |
| 2010 Q4 | 4 Million CNY | -71.43% |
| 2010 Q1 | 24.75 Million CNY | 80.0% |
| 2009 Q4 | 13.75 Million CNY | 0.0% |
| 2009 FY | 13.75 Million CNY | 14.58% |
| 2008 FY | 12 Million CNY | 20.0% |
| 2007 FY | 10 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.54 Billion CNY | 97.625% |
| Zhejiang Zhenyuan Share Co., Ltd. | 138.12 Million CNY | 56.267% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 593.88 Million CNY | 89.828% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 935.85 Million CNY | 93.545% |
| Yifan Pharmaceutical Co., Ltd. | 1.99 Billion CNY | 96.972% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 4.36 Million CNY | -1283.697% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.55 Billion CNY | 99.201% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 273.99 Million CNY | 77.953% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 62.44 Million CNY | 3.259% |